Welcome to our dedicated page for Dxp Enterprises SEC filings (Ticker: DXPE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
DXP Enterprises, Inc. filings document an operating company with common stock listed on the NASDAQ Global Select Market. Recent Form 8-K reports furnish Regulation FD earnings releases for quarterly and annual results, including press-release exhibits that describe sales, operating performance and non-GAAP measures such as Adjusted EBITDA.
The company’s proxy filings cover annual meeting governance matters, executive compensation, pay-versus-performance disclosures, equity awards and related shareholder information. Together, the filings provide formal records for DXPE’s public-company reporting, governance structure, registered common stock and periodic material-event disclosures tied to its industrial distribution business.
DXP Enterprises (DXPE) Form 144 summary: An individual intends to sell 6,000 common shares through UBS Financial Services, with an aggregate market value of $718,680. The proposed sale is listed for 08/13/2025 and the issuer's outstanding shares are reported as 15,694,084, so the block represents roughly 0.038% of outstanding stock.
The 6,000 shares correspond to specific ESPP purchases between 2016 and 2024 (lots of 418, 674, 134, 2,906, 104 and 1,764 shares). The filer reports "Nothing to Report" for securities sold in the past three months and includes the standard representation that no undisclosed material adverse information is known.
Gregory Christopher T, identified on the form as the company’s CIO, reported a non-derivative sale of DXP Enterprises Inc. common stock. On 08/12/2025 he sold 5,000 shares at $122 per share and, following the transaction, directly owned 24,436 shares. The filing lists no derivative holdings and includes no explanatory remarks.
DXP Enterprises filed a Form 144 notifying a proposed sale of 5,000 common shares, with an aggregate market value of $589,800. The shares are to be sold through Charles Schwab & Co and listed as to be traded on Nasdaq with an approximate sale date of 08/12/2025. The shares were acquired on 02/01/2023 as restricted stock issuances from the issuer. The filer reports no securities sold in the past three months for the account and represents that they do not possess undisclosed material adverse information about the issuer.
DXP Enterprises Inc. (DXPE) filed a Form 4 disclosing that director Karen Hoffman received a grant of 917 shares of common stock on 1 July 2025. The shares were recorded at an acquisition price of $90.04 and will fully vest one year from the grant date, per the filing’s footnote. Following the transaction, Hoffman’s direct ownership increased to 7,186 shares. No derivative transactions were reported and the filing was made individually by the director.
On 1 July 2025, Chief Operating Officer Nicholas Little submitted a Form 4 disclosing an insider sale at DXP Enterprises Inc. (DXPE). On 30 June 2025, he sold 45,938 common shares (transaction code “S”) at an average price of $87.73 per share, realising proceeds of roughly $4.0 million. After the transaction, the executive continues to hold 812,328 shares directly. No acquisitions or derivative security transactions were reported, and Little remains an officer of the company.